Archives
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
TG003: Selective Clk Family Kinase Inhibitor for Alternat...
2026-02-06
TG003 is a potent, selective Cdc2-like kinase inhibitor that enables precise modulation of alternative splicing in both cellular and animal models. Its nanomolar selectivity for Clk1, Clk2, and Clk4 positions it as a benchmark tool for splice site selection research and exon-skipping therapy development. As supplied by APExBIO, TG003 is widely used in cancer and neuromuscular disease models.
-
Meropenem Trihydrate in Translational Research: Mechanist...
2026-02-06
As multidrug-resistant bacterial infections escalate globally, translational researchers face the dual challenge of mechanistically characterizing resistance and rapidly advancing new diagnostic and therapeutic strategies. Meropenem trihydrate, a broad-spectrum carbapenem β-lactam antibiotic, stands at the intersection of cutting-edge systems biology, metabolomics, and translational science. This article integrates the latest mechanistic findings—highlighting the power of metabolomics for resistance phenotyping—with actionable guidance for experimental design and strategic innovation. We move beyond conventional product summaries, offering a holistic, forward-looking perspective for infection biologists, antimicrobial researchers, and laboratory leaders.
-
EdU Imaging Kits (Cy5): High-Fidelity Click Chemistry Cel...
2026-02-05
EdU Imaging Kits (Cy5) redefine cell proliferation research by enabling precise, morphology-preserving S-phase DNA synthesis measurement. Leveraging click chemistry, these kits surpass BrdU assays in sensitivity and workflow efficiency for both fluorescence microscopy and flow cytometry. Discover how APExBIO’s solution empowers advanced genotoxicity, pharmacodynamics, and cell health analytics.
-
EdU Imaging Kits (Cy5): Precision Cell Proliferation Assa...
2026-02-05
Unlock unprecedented accuracy in cell proliferation and DNA synthesis detection with EdU Imaging Kits (Cy5), featuring click chemistry for S-phase quantification. Streamline your fluorescence microscopy and flow cytometry workflows while preserving cellular integrity—ideal for advanced genotoxicity and pharmacodynamic research.
-
Bedaquiline: Transforming Tuberculosis and Cancer Research
2026-02-04
Bedaquiline stands at the intersection of infectious disease and oncology, offering a dual-action mechanism as both a Mycobacterium tuberculosis F1FO-ATP synthase inhibitor and a cancer stem cell inhibitor. This guide delivers actionable protocols, advanced troubleshooting, and forward-looking strategies—enabling researchers to unlock next-generation insights in tuberculosis and cancer research.
-
Angiotensin 1/2 (1-6): Mechanistic Precision in Renin-Ang...
2026-02-04
Angiotensin 1/2 (1-6), a hexapeptide fragment of the renin-angiotensin system, is a high-purity tool for cardiovascular regulation studies. This article details its molecular action, evidence base, and workflow parameters, providing benchmarks for hypertension research and vasoconstriction assays.
-
Talabostat Mesylate: Specific DPP4 and FAP Inhibitor for ...
2026-02-03
Talabostat mesylate (PT-100, Val-boroPro) is a potent, orally active inhibitor of DPP4 and FAP, widely used for dissecting tumor microenvironment and immune modulation in cancer biology. Its high specificity and well-characterized solubility profile enable reproducible results in both in vitro and in vivo research. This article consolidates recent evidence and optimal practices for deploying Talabostat mesylate in advanced translational studies.
-
Parathyroid hormone (1-34) (human): Reliable Solutions fo...
2026-02-03
This article provides scenario-driven guidance for biomedical researchers tackling cell viability, proliferation, or cytotoxicity assays using Parathyroid hormone (1-34) (human) (SKU A1129). Drawing on data-backed best practices and recent advancements in kidney assembloid models, it demonstrates how A1129 ensures reproducibility, sensitivity, and workflow robustness in bone and renal research.
-
Bedaquiline: Diarylquinoline Antibiotic for TB and Cancer...
2026-02-02
Bedaquiline stands out as a diarylquinoline antibiotic that disrupts energy metabolism in both Mycobacterium tuberculosis and cancer stem cells, offering applied utility across infectious disease and oncology pipelines. This guide unpacks experimental workflows, protocol optimizations, and troubleshooting strategies—empowering researchers to push the boundaries of multi-drug resistant tuberculosis and cancer stem cell inhibition studies.
-
Angiotensin 1/2 (1-6): Reliable Solutions for Cardiovascu...
2026-02-02
This article provides evidence-based guidance for laboratory teams facing challenges in cell viability, cytotoxicity, and mechanistic assays involving the renin-angiotensin system. Using SKU A1048, Angiotensin 1/2 (1-6), as a benchmark, we explore practical solutions for experimental design, data interpretation, and reagent selection—grounded in recent literature and rigorous quality standards.
-
TG003: A Selective Clk Family Kinase Inhibitor for Splice...
2026-02-01
TG003 is a potent and selective Clk family kinase inhibitor, empowering researchers to modulate alternative splicing, investigate platinum resistance in cancer, and advance exon-skipping therapies. Its robust performance and nanomolar selectivity streamline complex experimental workflows for both fundamental and translational research. Discover how TG003, supplied by APExBIO, is redefining the toolkit for splice site selection and disease modeling.
-
Real-World Reliability: EdU Imaging Kits (Cy5) for Cell P...
2026-01-31
This scenario-driven guide delivers evidence-based solutions to common laboratory challenges using EdU Imaging Kits (Cy5) (SKU K1076). Explore how the kit's click chemistry, cell morphology preservation, and robust fluorescence support reproducible cell proliferation, cytotoxicity, and genotoxicity assays in advanced research workflows.
-
EdU Imaging Kits (Cy5): Precision Cell Proliferation Anal...
2026-01-30
EdU Imaging Kits (Cy5) from APExBIO redefine cell proliferation assays with sensitive, morphology-preserving click chemistry detection. Unlock robust S-phase DNA synthesis measurement for both microscopy and flow cytometry, dramatically outperforming traditional BrdU methods in speed, accuracy, and data richness.
-
Talabostat Mesylate in Cancer: Inflammasome Modulation & ...
2026-01-30
Explore Talabostat mesylate's unique role in cancer biology as a specific inhibitor of DPP4 and FAP, with a deep dive into its impact on inflammasome pathways and tumor microenvironment modulation. This article uncovers advanced mechanisms and emerging applications beyond conventional protocols.
-
Meropenem Trihydrate: Carbapenem Antibiotic Workflows & R...
2026-01-29
Meropenem trihydrate empowers bench scientists to dissect antibiotic resistance and optimize infection research with robust, reproducible protocols. APExBIO's high-purity product supports everything from MIC assays to advanced metabolomics, offering the reliability and flexibility required for cutting-edge studies on gram-negative and gram-positive bacterial pathogens.